Bowles J, Mansoor M, Werb D, Kerr T, Bardwell G A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: motivations and initial impacts J Subst Use Addict Treat, 2024. PubMed


Fehr F, Lo LA, Nelson C, Nanson K, Diehl L, Nielson K, Reddon H, Walsh Z Stigma-related barriers to medical cannabis as harm reduction for substance use disorder: obstacles and opportunities for improvement Int J Ment Health Nurs, 2024. PubMed


Robinson K, Laing A, Choi J, Richardson L Effect of modified income assistance payment schedules on substance use service access: evidence from an experimental study Int J Drug Policy, 2024. PubMed


Kennedy MC, Tobias S, Dong H, Buxton JA, Lysyshyn M, Tupper KW, Ti L Author reply to letter to the editor in response to "Fentanyl concentration in drug checking samples and risk of overdose death in Vancouver, Canada" Am J Prev Med, 2024. PubMed


Wood E, Bach P Fatal drug overdose risks of health care workers in the United States Ann Intern Med, 2024. PubMed


Laing A, Richardson L Fronts and friends: social contingencies in the management of drug debt Sociol Q, 2024. Link


Fleming T, Boyd J, Chayama KL, Knight KR, McNeil R Using alone at home: What's missing in housing-based responses to the overdose crisis? Harm Reduct J, 2024. PubMed


Cui Z, Karamouzian M, Law M, Hayashi K, Milloy MJ, Kerr T The impact of longitudinal substance use patterns on the risk of opioid agonist therapy discontinuation: a repeated measures latent class analysis Int J Ment Health Addict, 2024. PubMed


Reddon H, Socías ME, DeBeck K, Hayashi K, Walsh Z, Milloy MJ Cannabis use to manage stimulant cravings among people who use unregulated drugs Addict Behav, 2024. PubMed


Kennedy MC, Dong H, Tobias S, Buxton J, Lysyshyn M, Tupper K, Ti L Fentanyl concentration in drug checking samples and risk of overdose death in Vancouver, Canada Am J Prev Med, 2024. PubMed